Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes.
Arch Pharm Res. 2018 Jul;41(7):691-710. doi: 10.1007/s12272-018-1055-x. Epub 2018 Jul 23.
Arch Pharm Res. 2018.
PMID: 30039377
Review.